A paper-based immunoassay to determine HPV vaccination status at the point-of-care

Benjamin D. Grant, Chelsey A. Smith, Philip E. Castle, Michael E. Scheurer, Rebecca Richards-Kortum

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. Methods The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. Results For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. Conclusions We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.

Original languageEnglish (US)
Pages (from-to)5656-5663
Number of pages8
JournalVaccine
Volume34
Issue number46
DOIs
StatePublished - Nov 4 2016

Fingerprint

Point-of-Care Systems
immunoassays
Immunoassay
Papillomavirus Vaccines
Vaccination
vaccination
Serology
Virion
Equipment and Supplies
virus-like particles
testing
Research Personnel
vaccines
Collodion
Serologic Tests
researchers
Immunization
Buffers
Cell Membrane
immunologic techniques

Keywords

  • HPV
  • Point-of-care testing
  • Serologic tests

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

A paper-based immunoassay to determine HPV vaccination status at the point-of-care. / Grant, Benjamin D.; Smith, Chelsey A.; Castle, Philip E.; Scheurer, Michael E.; Richards-Kortum, Rebecca.

In: Vaccine, Vol. 34, No. 46, 04.11.2016, p. 5656-5663.

Research output: Contribution to journalArticle

Grant, BD, Smith, CA, Castle, PE, Scheurer, ME & Richards-Kortum, R 2016, 'A paper-based immunoassay to determine HPV vaccination status at the point-of-care', Vaccine, vol. 34, no. 46, pp. 5656-5663. https://doi.org/10.1016/j.vaccine.2016.09.021
Grant, Benjamin D. ; Smith, Chelsey A. ; Castle, Philip E. ; Scheurer, Michael E. ; Richards-Kortum, Rebecca. / A paper-based immunoassay to determine HPV vaccination status at the point-of-care. In: Vaccine. 2016 ; Vol. 34, No. 46. pp. 5656-5663.
@article{b82714a31b4d43be83282f4416179fc3,
title = "A paper-based immunoassay to determine HPV vaccination status at the point-of-care",
abstract = "Objective To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. Methods The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. Results For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. Conclusions We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.",
keywords = "HPV, Point-of-care testing, Serologic tests",
author = "Grant, {Benjamin D.} and Smith, {Chelsey A.} and Castle, {Philip E.} and Scheurer, {Michael E.} and Rebecca Richards-Kortum",
year = "2016",
month = "11",
day = "4",
doi = "10.1016/j.vaccine.2016.09.021",
language = "English (US)",
volume = "34",
pages = "5656--5663",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "46",

}

TY - JOUR

T1 - A paper-based immunoassay to determine HPV vaccination status at the point-of-care

AU - Grant, Benjamin D.

AU - Smith, Chelsey A.

AU - Castle, Philip E.

AU - Scheurer, Michael E.

AU - Richards-Kortum, Rebecca

PY - 2016/11/4

Y1 - 2016/11/4

N2 - Objective To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. Methods The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. Results For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. Conclusions We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.

AB - Objective To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. Methods The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. Results For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. Conclusions We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.

KW - HPV

KW - Point-of-care testing

KW - Serologic tests

UR - http://www.scopus.com/inward/record.url?scp=84992365613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992365613&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2016.09.021

DO - 10.1016/j.vaccine.2016.09.021

M3 - Article

C2 - 27667331

AN - SCOPUS:84992365613

VL - 34

SP - 5656

EP - 5663

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 46

ER -